Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Windlas Biotech Adverse Business Impact

Windlas Biotech reported temporary production disruptions due to statewide labour unrest in Uttarakhand. Operations resumed quickly with management expecting no material impact on financial performance.

Source

BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Windlas Biotech Ltd: key numbers

Share price
₹876.10
Market cap
₹1,839 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
27.7×Sector 45.9×
Promoter holding
63.31%+0.00% QoQ
FII holding
2.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Windlas Biotech Ltd

All →

Other adverse business impact announcements

All →